Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 12/2017

01-12-2017 | Substantive Review

Leveraging the U.S. Criminal Justice System to Access Women for HIV Interventions

Authors: Jaimie P. Meyer, Dharushana Muthulingam, Nabila El-Bassel, Frederick L. Altice

Published in: AIDS and Behavior | Issue 12/2017

Login to get access

Abstract

The criminal justice (CJ) system can be leveraged to access women for HIV prevention and treatment programs. Research is lacking on effective implementation strategies tailored to the specific needs of CJ-involved women. We conducted a scoping review of published studies in English from the United States that described HIV interventions, involved women or girls, and used the CJ system as an access point for sampling or intervention delivery. We identified 350 studies and synthesized data from 42 unique interventions, based in closed (n = 26), community (n = 7), or multiple/other CJ settings (n = 9). A minority of reviewed programs incorporated women-specific content or conducted gender-stratified analyses. CJ systems are comprised of diverse access points, each with unique strengths and challenges for implementing HIV treatment and prevention programs for women. Further study is warranted to develop women-specific and trauma-informed content and evaluate program effectiveness.
Literature
1.
Farley JL, Mitty JA, Lally MA, Burzynski JN, Tashima K, Rich JD, et al. Comprehensive medical care among HIV-positive incarcerated women: the Rhode Island experience. J Womens Health Gend Based Med. 2000;9(1):51–6.CrossRefPubMed
2.
Beckwith CG, Zaller ND, Fu JJ, Montague BT, Rich JD. Opportunities to diagnose, treat, and prevent HIV in the criminal justice system. J Acquir Immune Defic Syndr. 2010;55(Suppl 1):S49–55.CrossRefPubMedPubMedCentral
3.
Spaulding AC, Seals RM, Page MJ, Brzozowski AK, Rhodes W, Hammett TM. HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS ONE. 2009;4(11):e7558.CrossRefPubMedPubMedCentral
4.
5.
6.
Jenness S, Neaigus A, Hagan H, Murrill C, Wendel T. Heterosexual HIV and sexual partnerships between injection drug users and noninjection drug users. AIDS Patient Care STDS. 2010;24(3):175–81.CrossRefPubMed
7.
El-Bassel N, Gilbert L, Wu E, Go H, Hill J. HIV and intimate partner violence among methadone-maintained women in New York City. Soc Sci Med. 2005;61(1):171–83.CrossRefPubMed
8.
El-Bassel N, Witte S, Wada T, Gilbert L, Wallace J. Correlates of partner violence among female street-based sex workers: substance abuse, history of childhood abuse, and HIV risks. AIDS Patient Care STDS. 2001;15(1):41–51.CrossRefPubMed
9.
Meyer J, Altice F. HIV in injection and other drug users. Sexually transmitted infections. 2nd ed. Amsterdam: Elsevier Publications; 2011.
10.
Binswanger IA, Merrill JO, Krueger PM, White MC, Booth RE, Elmore JG. Gender differences in chronic medical, psychiatric, and substance-dependence disorders among jail inmates. Am J Public Health. 2010;100(3):476–82.CrossRefPubMedPubMedCentral
11.
Maruschak LM, Beaver R. HIV in Prisons, 2008. Washington, D.C.: U.S. Department of Justice, Office of Justice Programs BoJS; 2009 December 2009. Report No.: NCJ 228307 Contract No.: NCJ 228307.
12.
Altice FL, Marinovich A, Khoshnood K, Blankenship KM, Springer SA, Selwyn PA. Correlates of HIV infection among incarcerated women: implications for improving detection of HIV infection. J Urban Health. 2005;82(2):312–26.CrossRefPubMedPubMedCentral
13.
Strathdee SA, West BS, Reed E, Moazan B, Azim T, Dolan K. Substance use and HIV among female sex workers and female prisoners: risk environments and implications for prevention, treatment, and policies. JAIDS. 2015;69:S110–7.PubMedPubMedCentral
14.
World Health Organization. Consolidated guidelines on HIV prevention, diagnosis, treatment, and care for key populations. Geneva: Switzerland; 2014.
15.
The White House Office of National AIDS Policy. National HIV/AIDS strategy for the United States: updated to 2020. Washington, D.C. 2015.
16.
17.
Wolitski RJ. Relative efficacy of a multisession sexual risk-reduction intervention for young men released from prisons in 4 states. Am J Public Health. 2006;96(10):1854–61.CrossRefPubMedPubMedCentral
18.
19.
Hatcher SS, Toldson IA, Godette DC, Richardson JB. Mental health, substance abuse, and HIV disparities in correctional settings: practice and policy implications for African Americans. J Health Care Poor Underserved. 2009;20(2 Suppl):6–16.CrossRefPubMed
20.
Springer S, Pesanti E, Hodges J, Macura T, Doros G, Altice F. Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. Clin Infect Dis. 2004;38(12):1754–60.CrossRefPubMed
21.
Baillargeon J, Borucki MJ, Zepeda S, Jenson HB, Leach CT. Antiretroviral prescribing patterns in the Texas prison system. Clin Infect Dis. 2000;31(6):1476–81.CrossRefPubMed
22.
Altice F, Kamarulzaman A, Soriano V, Schechter M, Friedland G. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376(9738):367–87.CrossRefPubMedPubMedCentral
23.
Meyer JP, Cepeda J, Taxman FS, Altice FL. Sex-related disparities in criminal justice and HIV treatment outcomes: a retrospective cohort study of HIV-infected inmates. Am J Public Health. 2015;105(9):1901–10.CrossRefPubMedPubMedCentral
24.
Meyer JP, Zelenev A, Wickersham JA, Williams CT, Teixeira PA, Altice FL. Gender disparities in HIV treatment outcomes following release from jail: results from a multicenter study. Am J Public Health. 2014;104(3):434–41.CrossRefPubMedPubMedCentral
25.
Chandler RK, Fletcher BW, Volkow ND. Treating drug abuse and addiction in the criminal justice system: improving public health and safety. JAMA. 2009;301(2):183–90.CrossRefPubMedPubMedCentral
26.
Flanigan T, Zaller N, Beckwith CG, Bazerman LB, Rana A, Gardner A, et al. Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: still a missed opportunity for public health and HIV prevention. J Acquir Immune Defic Syndr. 2010;55(Suppl 2):S78–83.CrossRefPubMed
27.
Lichtenstein B, Malow R. A critical review of HIV-related interventions for women prisoners in the United States. J Assoc Nurses AIDS Care. 2010;21(5):380–94.CrossRefPubMedPubMedCentral
28.
Underhill K, Dumont D, Operario D. HIV prevention for adults with criminal justice involvement: a systematic review of HIV risk-reduction interventions in incarceration and community settings. Am J Public Health. 2014;104(11):e27–53.CrossRefPubMedPubMedCentral
29.
Azhar SV, Berringer KR, Epperson MW. A systematic review of HIV prevention interventions targeting women with criminal justice involvement. J Soc Soc Work Res. 2014;5(3):253–89.CrossRef
30.
Armstrong R, Hall BJ, Doyle J, Waters E. Cochrane update. ‘Scoping the scope’ of a cochrane review. J Public Health. 2011;33(1):147–50.CrossRef
31.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med. 2009;3(3):e123–30.PubMedPubMedCentral
32.
33.
Kavasery R, Maru DS, Cornman-Homonoff J, Sylla LN, Smith D, Altice FL. Routine opt-out HIV testing strategies in a female jail setting: a prospective controlled trial. PLoS ONE. 2009;4(11):e7648.CrossRefPubMedPubMedCentral
34.
Saber-Tehrani AS, Springer SA, Qiu J, Herme M, Wickersham J, Altice FL. Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community—a potential conduit to improved HIV treatment outcomes. Contemp Clin Trials. 2011;33:436–44.CrossRefPubMed
35.
White BL, Golin CE, Grodensky CA, Kiziah CN, Richardson A, Hudgens MG, et al. Effect of directly observed antiretroviral therapy compared to self-administered antiretroviral therapy on adherence and virological outcomes among HIV-infected prisoners: a randomized controlled pilot study. AIDS Behav. 2015;19(1):128–36.CrossRefPubMedPubMedCentral
36.
Rich JD, McKenzie M, Larney S, Wong JB, Tran L, Clarke J, et al. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial. Lancet. 2015;386(9991):350–9.CrossRefPubMedPubMedCentral
37.
Springer S, Chen S, Altice F. Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment. J Urban Health. 2010;87(4):592–602.CrossRefPubMedPubMedCentral
38.
Knudsen HK, Staton-Tindall M, Oser CB, Havens JR, Leukefeld CG. Reducing risky relationships: a multisite randomized trial of a prison-based intervention for reducing HIV sexual risk behaviors among women with a history of drug use. AIDS Care. 2014;26(9):1071–9.CrossRefPubMedPubMedCentral
39.
Fogel CI, Crandell JL, Neevel AM, Parker SD, Carry M, White BL, et al. Efficacy of an adapted HIV and sexually transmitted infection prevention intervention for incarcerated women: a randomized controlled trial. Am J Public Health. 2015;105(4):802–9.CrossRefPubMedPubMedCentral
40.
Sacks JY, McKendrick K, Hamilton Z. A randomized clinical trial of a therapeutic community treatment for female inmates: outcomes at 6 and 12 months after prison release. J Addict Dis. 2012;31(3):258–69.CrossRefPubMed
41.
St. Lawrence JS, Eldridge GD, Shelby MC, Little CE, Brasfield TL, O’Bannon IRE. HIV risk reduction for incarcerated women: a comparison of brief interventions based on two theoretical models. J Consult Clin Psychol. 1997;65(3):504–9.CrossRefPubMed
42.
El-Bassel N, Gilbert L, Goddard-Eckrich D, Chang M, Wu E, Hunt T, et al. Efficacy of a group-based multimedia HIV prevention intervention for drug-involved women under community supervision: project WORTH. PLoS ONE. 2014;9(11):e111528.CrossRefPubMedPubMedCentral
43.
Grinstead Reznick O, Comfort M, McCartney K, Neilands TB. Effectiveness of an HIV prevention program for women visiting their incarcerated partners: the HOME project. AIDS Behav. 2011;15(2):365–75.CrossRefPubMed
44.
Martin SS, O’Connell DJ, Inciardi JA, Surratt HL, Maiden KM. Integrating an HIV/HCV brief intervention in prisoner reentry: results of a multisite prospective study. J Psychoact Drugs. 2008;40(4):427–36.CrossRef
45.
Rhodes W, Gross M. Case management reduces drug use and criminality among drug-involved arrestees: an experimental study of an HIV prevention intervention. Rockville, MD: National Institute of Justice and the National Institute on Drug Abuse; 1997.
46.
Straub DM, Pomputius P, Boyer CB, Someillan NS, Perrin K. HIV prevention education and testing among youth: is there a correlation? J Adolesc Health. 2007;41(1):105–7.CrossRefPubMed
47.
Kelly PJ, Owen SV, Peralez-Dieckmann E, Martinez E. Health interventions with girls in the juvenile justice system. Womens Health Issues. 2007;17(4):227–36.CrossRefPubMed
48.
Mahoney M, Bien M, Comfort M. Adaptation of an evidence-based HIV prevention intervention for women with incarcerated partners: expanding to community settings. AIDS Educ Prev. 2013;25(1):1–13.CrossRefPubMed
49.
Tolou-Shams M, Houck C, Conrad SM, Tarantino N, Stein LA, Brown LK. HIV prevention for juvenile drug court offenders: a randomized controlled trial focusing on affect management. J Correct Health Care. 2011;17(3):226–32.CrossRefPubMedPubMedCentral
50.
Weir BW, O’Brien K, Bard RS, Casciato CJ, Maher JE, Dent CW, et al. Reducing HIV and partner violence risk among women with criminal justice system involvement: a randomized controlled trial of two motivational interviewing-based interventions. AIDS Behav. 2009;13(3):509–22.CrossRefPubMed
51.
Springer SA, Spaulding A, Meyer JP, Altice FL. Public health implications for adequate transitional care for HIV-Infected prisoners: five essential components. Clin Infect Dis. 2011;53(5):469–79.CrossRefPubMedPubMedCentral
52.
Lichtenstein B, Barber BW. A partnership approach to providing on-site HIV services for probationers and parolees: a pilot study from Alabama, USA. J Int AIDS Soc. 2016;19(4 Suppl 3):20868.PubMedPubMedCentral
53.
Trestman RL, Ferguson W, Dickert J. Behind bars: the compelling case for academic health centers partnering with correctional facilities. Acad Med. 2015;90(1):16–9.CrossRefPubMed
54.
55.
56.
El-Bassel N, Terlikbaeva A, Pinkham S. HIV and women who use drugs: double neglect, double risk. Lancet. 2010;376(9738):312–4.CrossRefPubMed
57.
El-Bassel N, Wechsberg WM, Shaw SA. Dual HIV risk and vulnerabilities among women who use or inject drugs: no single prevention strategy is the answer. Curr Opin HIV AIDS. 2012;7(4):326–31.CrossRefPubMed
58.
Williams CT, Kim S, Meyer J, Spaulding A, Teixeira P, Avery A, et al. Gender differences in baseline health, needs at release, and predictors of care engagement among HIV-positive clients leaving jail. AIDS Behav. 2013;17:195–202.CrossRefPubMedCentral
59.
Meyer JP, Zelenev A, Wickersham JA, Williams CT, Teixeira PA, Altice FL. Gender disparities in HIV treatment outcomes following release from jail: results from a multicenter study. Am J Public Health. 2014;104:434–41.CrossRefPubMedPubMedCentral
60.
Meyer JP, Cepeda J, Taxman FS, Altice FL. Sex-Related disparities in criminal justice and HIV treatment outcomes: a retrospective cohort study of HIV-infected inmates. Am J Public Health. 2015;105:e1–10.CrossRef
61.
Belenko S, Dembo R, Copenhaver M, Hiller M, Swan H, Albizu Garcia C, et al. HIV stigma in prisons and jails: results from a staff survey. AIDS Behav. 2016;20(1):71–84.CrossRefPubMedPubMedCentral
62.
World Health Organization. Tool to set and monitor targets for HIV preventions, diagnosis, treatment, and care for key populations: supplement to the 2014 consolidated guidelines for HIV prevention, diagnosis, treatment, and care for key populations Geneva, Switzerland: 2015.
63.
Lambdin BH, Cheng B, Peter T, Mbwambo J, Apollo T, Dunbar M, et al. Implementing implementation science: an approach for HIV prevention, care and treatment programs. Curr HIV Res. 2015;13(3):244–9.CrossRefPubMedPubMedCentral
64.
Loeliger KB, Biggs ML, Young R, Kahana SY, Seal DW, Beckwith CG, et al. Gender differences in HIV risk behaviors among persons involved in the U.S. criminal justice system and living with HIV or at risk for HIV: a “seek, test, treat, and retain” harmonization consortium. AIDS Behav. 2017; In press.
65.
Bryan AD, Schmiege SJ, Broaddus MR. HIV risk reduction among detained adolescents: a randomized, controlled trial. Pediatrics. 2009;124(6):e1180–8.CrossRefPubMed
66.
DiClemente RJ, Davis TL, Swartzendruber A, Fasula AM, Boyce L, Gelaude D, et al. Efficacy of an HIV/STI sexual risk-reduction intervention for African American adolescent girls in juvenile detention centers: a randomized controlled trial. Women Health. 2014;54(8):726–49.CrossRefPubMedPubMedCentral
67.
El-Bassel N, Ivanoff A, Schilling RF, Gilbert L, Borne D, Chen DR. Preventing HIV/AIDS in drug-abusing incarcerated women through skills building and social support enhancement: preliminary outcomes. Soc Work Res. 1995;19(3):131–41.PubMed
68.
Fasula AM, Fogel CI, Gelaude D, Carry M, Gaiter J, Parker S. Project power: adapting an evidence-based HIV/STI prevention intervention for incarcerated women. AIDS Educ Prev. 2013;25(3):203–15.CrossRefPubMed
69.
Fogel CI, Gelaude DJ, Carry M, Herbst JH, Parker S, Scheyette A, et al. Context of risk for HIV and sexually transmitted infections among incarcerated women in the south: individual, interpersonal, and societal factors. Women Health. 2014;54(8):694–711.CrossRefPubMed
70.
Havens JR, Leukefeld CG, Oser CB, Staton-Tindall M, Knudsen HK, Mooney J, et al. Examination of an interventionist-led HIV intervention among criminal justice-involved female prisoners. J Exp Criminol. 2009;5(3):245–72.CrossRefPubMedPubMedCentral
71.
Leukefeld C, Havens J, Tindall MS, Oser CB, Mooney J, Hall MT, et al. Risky relationships: targeting HIV prevention for women offenders. AIDS Educ Prev. 2012;24(4):339–49.CrossRefPubMedPubMedCentral
72.
Myers J, Zack B, Kramer K, Gardner M, Rucobo G, Costa-Taylor S. Get connected: an HIV prevention case management program for men and women leaving California prisons. Am J Public Health. 2005;95(10):1682–4.CrossRefPubMedPubMedCentral
73.
Needels K, James-Burdumy S, Burghardt J. Community case management for former jail inmates: its impacts on rearrest, drug use, and HIV risk. J Urban Health. 2005;82(3):420–33.CrossRefPubMedPubMedCentral
74.
Richie BE, Freudenberg N, Page J. Reintegrating women leaving jail into urban communities: a description of a model program. J Urban Health. 2001;78(2):290–303.CrossRefPubMedPubMedCentral
75.
Robertson AA, St Lawrence J, Morse DT, Baird-Thomas C, Liew H, Gresham K. The healthy teen girls project: comparison of health education and STD risk reduction intervention for incarcerated adolescent females. Health Educ Behav. 2011;38(3):241–50.CrossRefPubMedPubMedCentral
76.
Schlapman N, Cass PS. Project: HIV prevention for incarcerated youth in Indiana. J Community Health Nurs. 2000;17(3):151–8.CrossRefPubMed
77.
Schmiege SJ, Broaddus MR, Levin M, Bryan AD. Randomized trial of group interventions to reduce HIV/STD risk and change theoretical mediators among detained adolescents. J Consult Clin Psychol. 2009;77(1):38–50.CrossRefPubMed
78.
Schmiege SJ, Feldstein Ewing SW, Hendershot CS, Bryan AD. Positive outlook as a moderator of the effectiveness of an HIV/STI intervention with adolescents in detention. Health Educ Res. 2011;26(3):432–42.CrossRefPubMed
79.
Scott CK, Dennis ML. The first 90 days following release from jail: findings from the recovery management checkups for women offenders (RMCWO) experiment. Drug Alcohol Depend. 2012;125(1–2):110–8.CrossRefPubMedPubMedCentral
80.
St. Lawrence JS, Eldridge GD, Shelby MC, Little CE, Brasfield TL, O’Bannon IRE. HIV risk reduction for incarcerated women: A comparison of brief interventions based on two theoretical models. Journal of Consulting and Clinical Psychology. 1997;65(3):504–9.
81.
Vigilante KC, Flynn MM, Affleck PC, Stunkle JC, Merriman NA, Flanigan TP, et al. Reduction in recidivism of incarcerated women through primary care, peer counseling, and discharge planning. J Womens Health. 1999;8(3):409–15.CrossRefPubMed
82.
Di Paola A, Lincoln T, Skiest DJ, Desabrais M, Altice FL, Springer SA. Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community. Contemp Clin Trials. 2014;39(2):256–68.CrossRefPubMedPubMedCentral
83.
Springer SA, Brown SE, Di Paola A. Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system. Drug Alcohol Depend. 2015;157:158–65.CrossRefPubMedPubMedCentral
84.
Kim JY, Rich J, Zierler S, Lourie K, Vigilante K, Normandie L, et al. Successful community follow-up and reduced recidivism in HIV positive women prisoners. J Correct Health Care. 1997;4(1):5–17.CrossRef
85.
MacGowan RJ, Lifshay J, Mizuno Y, Johnson WD, McCormick L, Zack B. Positive transitions (POST): evaluation of an HIV prevention intervention for HIV-positive persons releasing from correctional facilities. AIDS Behav. 2015;19(6):1061–9.CrossRefPubMed
86.
Pomeroy EC, Kiam R, Abel EM. The effectiveness of a psychoeducational group for HIV-infected/affected incarcerated women. Res Soc Work Pract. 1999;9(2):171–87.CrossRef
87.
Reznick OG, McCartney K, Gregorich SE, Zack B, Feaster DJ. An ecosystem-based intervention to reduce HIV transmission risk and increase medication adherence among inmates being released to the community. J Correct Health Care. 2013;19(3):178–93.CrossRefPubMedPubMedCentral
88.
Saber-Tehrani AS, Springer SA, Qiu J, Herme M, Wickersham J, Altice FL. Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community - A potential conduit to improved HIV treatment outcomes. Contemp Clin Trials. 2011.
89.
Altice F, Saber-Tehrani A, Qiu J, Herme M. Abstract #543: DAART is superior to self-administered therapy among released HIV+ prisoners: results from a randomized controlled trial. Boston: CROI; 2011.
90.
Wohl DA, Scheyett A, Golin CE, White B, Matuszewski J, Bowling M, et al. Intensive case management before and after prison release is no more effective than comprehensive pre-release discharge planning in linking HIV-infected prisoners to care: a randomized trial. AIDS Behav. 2011;15(2):356–64.CrossRefPubMedPubMedCentral
91.
Zaller ND, Holmes L, Dyl AC, Mitty JA, Beckwith CG, Flanigan TP, et al. Linkage to treatment and supportive services among HIV-positive ex-offenders in Project Bridge. J Health Care Poor Underserved. 2008;19(2):522–31.CrossRefPubMed
92.
Alemagno SA, Stephens RC, Stephens P, Shaffer-King P, White P. Brief motivational intervention to reduce HIV risk and to increase HIV testing among offenders under community supervision. J Correct Health Care. 2009;15(3):210–21.CrossRefPubMed
93.
94.
Gordon MS, Kinlock TW, McKenzie M, Wilson ME, Rich JD. Rapid HIV testing for individuals on probation/parole: outcomes of an intervention trial. AIDS Behav. 2013;17(6):2022–30.CrossRefPubMedPubMedCentral
95.
Nydegger LA, Keeler AR, Hood C, Siegel JT, Stacy AW. Effects of a one-hour intervention on condom implementation intentions among drug users in Southern California. AIDS Care. 2013;25(12):1586–91.CrossRefPubMedPubMedCentral
96.
Prendergast M, Frisman L, Sacks JY, Staton-Tindall M, Greenwell L, Lin HJ, et al. A multi-site, randomized study of strengths-based case management with substance-abusing parolees. J Exp Criminol. 2011;7(3):225–53.CrossRefPubMedPubMedCentral
97.
Grinstead O, Comfort M, McCartney K, Koester K, Neilands T. Bringing it home: Design and implementation of an HIV/STD intervention for women visiting incarcerated men. AIDS Educ Prev. 2008;20(4):285–300.CrossRefPubMed
98.
Mallory C, Hesson-McInnis M. Pilot test results of an HIV prevention intervention for high-risk women. West J Nurs Res. 2013;35(3):313–29.CrossRefPubMed
99.
Rhodes W, Gross M. Case Management Reduces Drug Use and Criminality Among Drug-Involved Arrestees: An Experimental Study of an HIV Prevention Intervention. Rockville, MD: 1997.
100.
Hser YI, Fu L, Wu F, Du J, Zhao M. Pilot trial of a recovery management intervention for heroin addicts released from compulsory rehabilitation in China. J Subst Abuse Treat. 2013;44(1):78–83.CrossRefPubMed
101.
Goldberg E, Millson P, Rivers S, Manning SJ, Leslie K, Read S, et al. A human immunodeficiency virus risk reduction intervention for incarcerated youth: a randomized controlled trial. J Adolesc Health. 2009;44(2):136–45.CrossRefPubMed
102.
Gilbert L, Goddard-Eckrich D, Hunt T, Ma X, Chang M, Rowe J, et al. Efficacy of a computerized intervention on HIV and intimate partner violence among substance-using women in community corrections: a randomized controlled trial. Am J Public Health. 2016;106:e1–9.CrossRef
Metadata
Title
Leveraging the U.S. Criminal Justice System to Access Women for HIV Interventions
Authors
Jaimie P. Meyer
Dharushana Muthulingam
Nabila El-Bassel
Frederick L. Altice
Publication date
01-12-2017
Publisher
Springer US
Published in
AIDS and Behavior / Issue 12/2017
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-017-1778-6

Other articles of this Issue 12/2017

AIDS and Behavior 12/2017 Go to the issue

Original Paper

Financial Hardship, Condomless Anal Intercourse and HIV Risk Among Men Who Have Sex with Men

Original Paper

Caregivers’ Support Network Characteristics Associated with Viral Suppression among HIV Care Recipients

Original Paper

Ethnicity, Sex Work, and Incident HIV/STI Among Transgender Women in New York City: A Three Year Prospective Study

Original Paper

Impact of Food Insecurity on Depressive Symptoms Among HIV–HCV Co-infected People

Original Paper

HIV Prevalence, Sexual Partners, Sexual Behavior and HIV Acquisition Risk Among Trans Men, San Francisco, 2014

Brief Report

Mental Health Disorders and Publicly Funded Service Use by HIV Positive Individuals: A Population-Based Cross-Sectional Study in Ontario, Canada
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits